Nova Biomedical Corporation

Nova Biomedical Corporation — FDA 510(k) Submissions

Nova Biomedical Corporation has submitted 40 FDA 510(k) premarket notifications since 2011, of which 40 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Prescription Use Blood Glucose Meter For Near-patient Testing, Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph, System, Test, Blood Glucose, Over The Counter, Glucose Oxidase, Glucose, Electrode, Ion Specific, Sodium . Use the specialty filter in the sidebar to narrow results.